TR201714893A1 - Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. - Google Patents
Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. Download PDFInfo
- Publication number
- TR201714893A1 TR201714893A1 TR2017/14893A TR201714893A TR201714893A1 TR 201714893 A1 TR201714893 A1 TR 201714893A1 TR 2017/14893 A TR2017/14893 A TR 2017/14893A TR 201714893 A TR201714893 A TR 201714893A TR 201714893 A1 TR201714893 A1 TR 201714893A1
- Authority
- TR
- Turkey
- Prior art keywords
- dry powder
- corticosteroid
- agonist
- composition containing
- powder composition
- Prior art date
Links
- 239000000843 powder Substances 0.000 title abstract 2
- 229940124748 beta 2 agonist Drugs 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 abstract 1
- 229940092705 beclomethasone Drugs 0.000 abstract 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, formoterol ve beklometazondan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/14893A TR201714893A1 (tr) | 2017-10-03 | 2017-10-03 | Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. |
| TR2017/16235A TR201716235A2 (tr) | 2017-09-30 | 2017-10-20 | Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim |
| TR2017/16233A TR201716233A2 (tr) | 2017-09-30 | 2017-10-20 | Solunum yolları hastalıklarının tedavisi için birden fazla etken madde içeren farmasötik bileşim. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/14893A TR201714893A1 (tr) | 2017-10-03 | 2017-10-03 | Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201714893A1 true TR201714893A1 (tr) | 2019-04-22 |
Family
ID=67981806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/14893A TR201714893A1 (tr) | 2017-09-30 | 2017-10-03 | Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201714893A1 (tr) |
-
2017
- 2017-10-03 TR TR2017/14893A patent/TR201714893A1/tr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120684T1 (el) | Σκευασμα ξηρης σκονης που περιλαμβανει ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης | |
| EP3630145A4 (en) | PHARMACEUTICAL COMPOSITIONS OF CANNABIDIOL AND BETA-CARYOPHYLLENE AND METHOD FOR USING THEM | |
| BR112015018087A8 (pt) | composto, composição farmacêutica e uso | |
| MX2015015132A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
| TR201000681A2 (tr) | İnhalasyon yoluyla alınan kuru toz formülasyonları. | |
| MX2019003685A (es) | Composicion farmaceutica para uso en el tratamiento terapeutico del cancer y complicaciones del cancer. | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
| MX2018014790A (es) | Formulacion combinada de tres compuestos antivirales. | |
| TR201902687T4 (tr) | İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler. | |
| EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
| TR201714893A1 (tr) | Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. | |
| PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
| TR201714728A1 (tr) | Beta-2 Agonist ve Kortikosteroid içeren kuru toz formülasyonu. | |
| TR201714725A1 (tr) | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu | |
| IT201700025738A1 (it) | Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico | |
| TR201716155A1 (tr) | Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon. | |
| TR201716207A2 (tr) | Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. | |
| EA201890789A1 (ru) | Содержащая цинеол композиция для лечения заболеваний носа | |
| TR200907913A2 (tr) | İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim | |
| EP3210614A4 (en) | Composition containing thymosin beta 4, and pharmaceutical formulation comprising same | |
| MX2019015869A (es) | Nuevas formulaciones orales de belinostat. | |
| TR201712424A2 (tr) | Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ | |
| EA201891848A1 (ru) | Фармацевтическая композиция для применения в лечении фиброза | |
| TR201716201A2 (tr) | Beta-2 agonisti içeren kuru toz formülasyonu. |